Patrice M Becker

11PUBLICATIONS
75CO-AUTHORS
Medical virologyInnate immunityPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Abigail Glascock, Cole Maguire, Hoang Van Phan

|Feb 23, 2026
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena

|Jan 03, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena

|Sep 02, 2025
Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma.

Courtney L Gaberino, R Max Segnitz, Kimberly A Dill-McFarland

|Jun 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.

Charles Langelier, Abigail Glascock, Cole Maguire

|Jan 10, 2025
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients.

Harry Pickering, Joanna Schaenman, Hoang Van Phan

Pageof 2

Frequent Collaborators

10 joint publications

Holden T Maecker

9 joint publications

Charles R Langelier

9 joint publications

Al Ozonoff

9 joint publications

Matthew C Altman